HCPCS Code J0885: Injection, Epoetin Alfa, (for Non-ESRD Use), 1000 Units

HCPCS Code J0885: Injection, Epoetin Alfa, (for Non-ESRD Use), 1000 Units

Learn about the HCPCS code J0885 for "injection, epoetin alfa, (for non-ESRD use), 1000 units" through this short guide.

Use Code
## **What is the HCPCS code J0885 for?** The HCPCS code J0885 is meant to designate the provision of an epoetin alfa injection, specifically 1,000 units. This injection is an erythropoiesis-stimulating agent (ESAS). What this kind of medicine does is stimulate the production of red blood cells (RBC). This is usually provided to treat anemia because stimulating red blood cell production helps combat the potential fatigue and weakness often associated with anemia that results from chronic diseases. It can also be used on patients with chronic kidney disease stages (a.k.a. chronic renal failure) that aren't considered end-stage renal disease, chemotherapy-induced anemia in cancer patients, certain HIV treatments, symptomatic anemia in patients with myelodysplastic syndromes (MDS), and pre-operative anemia. It is not yet known if this is viable for those with anemia due to hepatitis C treatment, anemia in Castleman's disease, anemia in Gaucher's disease, and more. Studies are currently ongoing to see if they are viable for such kinds of anemia.
## **Documentation requirements for J0885** As with any HCPCS code, please make sure you familiarize yourself with documentation requirements based on your insurer's guidelines (e.g., Medicare benefit policy manual, related local coverage determinations, etc.). Here are examples of what you might need: - The full name of the patient - The full names and credentials of the professionals handling the patient - The name and address of the facility where this injection was administered - Relevant information and indications related to the patient's condition (having uncontrolled hypertension as a result of anemia, having anemia associated with cancer and related neoplastic conditions, etc.) to justify medical necessity - Drug name of the ESA administered to treat anemia, dose, and strength administered (in units) - Total number of units given (rounded to the nearest billing unit) - Route of administration (subcutaneous) - Lot number, manufacturer, National Drug Code, and expiration date of the injection - Blood test results (must have hemoglobin/hematocrit counts) - Imaging test results that show cancerous tumors (if applicable)
## **Billing requirements for J0885** Besides the documentation requirements above, please take note of or have the following: - 1 unit of service is equal to 1000 units of epoetin alfa. Report total units based on the drug amount administered - The relevant ICD code related to your patient's condition (e.g., D64.81 - Anemia due to antineoplastic chemotherapy; D63.8 - Anemia in other chronic diseases classified elsewhere; N18.9 - Unspecified chronic kidney disease) - CPT code 96372, since this is injected subcutaneously - Use either of two modifiers: JW if there's unused medication in a vial (wastage), or JZ if there's no unused medication Furthermore, claims for J0885 must include one of these modifiers to specify the cause of the anemia: - **EA**: ESA administered to treat anemia due to anti-cancer chemotherapy. - **EB**: ESA administered to treat anemia due to anti-cancer radiotherapy (Note: Coverage for EB may be heavily restricted or denied by many MACs). - **EC**: ESA administered to treat anemia not due to anti-cancer radiotherapy or chemotherapy (e.g., CKD not on dialysis, MDS, HIV). Please familiarize yourself with the necessary coding guidelines and requirements set and demanded by your ensurer, and make sure you understand the difference between filing professional paper claims and electronic claims. It's best to know what is asked of you and update yourself with any new changes made to policies so you can avoid claim rejections.
## **Other similar codes** - **J0887** - Injection, epoetin beta, 1 microgram, (for esrd on dialysis) - **J0888** - Injection, epoetin beta, 1 microgram, (for non esrd use) - **J0881** - Injection, darbepoetin alfa, 1 microgram (non-esrd use) - **J0882** - Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)

Frequently asked questions

It can take up to 30 minutes, counting preparation time. It might take longer for monitoring purposes.

The serious problems (albeit rare ones) that you need to look out for are allergic reactions to the injection, hypertension, blood clot formations, and an increased risk of stroke.

It'll take a few days. However, this is only for anemia. If the anemia is caused by an underlying condition, that condition also needs to be treated to get an overall picture of the patient's health.

EHR and practice management software

Get started for free

*No credit card required

Free

$0/usd

Unlimited clients

Telehealth

1GB of storage

Client portal text

Automated billing and online payments